학술논문

Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads.
Document Type
Article
Source
Journal of Medicinal Chemistry; 3/24/2022, Vol. 65 Issue 6, p4600-4615, 16p
Subject
Language
ISSN
00222623